"Mir ward es seltsam kalt." Weiblichkeit und Tod in Heinrich Manns Frühwerk Jan Christian Metzler

Autor: Wolf, Gregory H.

Publikováno v: The German Quarterly, 2002 Jul 01. 75(3), 322-323.

Externí odkaz: https://www.jstor.org/stable/3072722

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

'Mir ward es seltsam kalt.' Weiblichkeit und Tod in Heinrich Manns Fruhwerk

Autor: Gregory H. Wolf, Jan Christian Metzler

Publikováno v: The German Quarterly. 75:322

Metzler, Jan Christian. "Mir ward es seltsam kalt." Weiblichkeit and Tod in Heinrich Manns Fruhwerk. Hamburg: Argument, 2000. 217 pp. EUR17.79 paperback. Though the tradition of coupling womanhood and death in European art and literature extends from

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d683ac27d07cb688bd1ee8d5aad3a888
https://doi.org/10.2307/3072722

IL-6-mediated endothelial injury impairs antiviral humoral immunity after bone marrow transplantation.

Autor: Zhang P; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Fleming P; Infection and Immunity Program and Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.; Centre for Experimental Immunology, Lions Eye Institute, Nedlands, Western Australia, Australia., Andoniou CE; Infection and Immunity Program and Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.; Centre for Experimental Immunology, Lions Eye Institute, Nedlands, Western Australia, Australia., Waltner OG; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Bhise SS; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Martins JP; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., McEnroe BA; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Voigt V; Centre for Experimental Immunology, Lions Eye Institute, Nedlands, Western Australia, Australia., Daly S; Centre for Experimental Immunology, Lions Eye Institute, Nedlands, Western Australia, Australia., Kuns RD; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Ekwe AP; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Henden AS; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; University of Queensland, St Lucia, Queensland, Australia.; Royal Brisbane and Women's Hospital, Herston, Queensland, Australia., Saldan A; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; University of Queensland, St Lucia, Queensland, Australia., Olver S; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Varelias A; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; University of Queensland, St Lucia, Queensland, Australia., Smith C; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Schmidt CR; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Ensbey KS; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Legg SR; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Sekiguchi T; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Minnie SA; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Gradwell M; Cancer Sciences Unit, Centre for Cancer Immunology, University of Southampton, Southampton, United Kingdom., Wagenaar I; Cancer Sciences Unit, Centre for Cancer Immunology, University of Southampton, Southampton, United Kingdom., Clouston AD; Envoi Pathology, Brisbane, Queensland, Australia., Koyama M; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Furlan SN; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Department of Pediatrics and., Kennedy GA; University of Queensland, St Lucia, Queensland, Australia.; Royal Brisbane and Women's Hospital, Herston, Queensland, Australia., Ward ES; Cancer Sciences Unit, Centre for Cancer Immunology, University of Southampton, Southampton, United Kingdom., Degli-Esposti MA; Infection and Immunity Program and Department of Microbiology, Biomedicine Discovery Institute, Monash University, Clayton, Victoria, Australia.; Centre for Experimental Immunology, Lions Eye Institute, Nedlands, Western Australia, Australia., Hill GR; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.; Division of Medical Oncology, University of Washington, Seattle, Washington, USA., Tey SK; QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia.; University of Queensland, St Lucia, Queensland, Australia.; Royal Brisbane and Women's Hospital, Herston, Queensland, Australia.

Publikováno v: The Journal of clinical investigation [J Clin Invest] 2024 Apr 01; Vol. 134 (7). Date of Electronic Publication: 2024 Apr 01.

Treatment of pemphigus vulgaris and foliaceus with efgartigimod, a neonatal Fc receptor inhibitor: a phase II multicentre, open-label feasibility trial.

Autor: Goebeler M; Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany., Bata-Csörgő Z; Department of Dermatology and Allergology, University of Szeged, Szeged, Hungary., De Simone C; Department of Dermatology, Catholic University of the Sacred Heart, Policlinic A. Gemelli, Rome, Italy., Didona B; Dermatopathic Institute of the Immaculate, Rome, Italy., Remenyik E; Department of Dermatology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary., Reznichenko N; Zaporizhzhya State Medical University, Zaporizhzhya, Ukraine., Stoevesandt J; Department of Dermatology, Venereology and Allergology, University Hospital Würzburg, Würzburg, Germany., Ward ES; Centre for Cancer Immunology, University of Southampton, Southampton, UK., Parys W; argenx, Ghent, Belgium., de Haard H; argenx, Ghent, Belgium., Dupuy P; argenx, Ghent, Belgium., Verheesen P; argenx, Ghent, Belgium., Schmidt E; Department of Dermatology, University of Lübeck, Lübeck, Germany., Joly P; Department of Dermatology, Rouen University Hospital, Rouen, France.

Publikováno v: The British journal of dermatology [Br J Dermatol] 2022 Mar; Vol. 186 (3), pp. 429-439. Date of Electronic Publication: 2021 Nov 28.